The Effect of Fish Oil Supplementation on Endothelial Function, Heart Rate Variability and Intimal Media Thickness of Patients With Coronary Artery Disease

Last updated: March 11, 2019
Sponsor: Olive View-UCLA Education & Research Institute
Overall Status: Completed

Phase

N/A

Condition

Chest Pain

Myocardial Ischemia

Heart Disease

Treatment

N/A

Clinical Study ID

NCT00454493
05H-561610
  • Ages 18-75
  • All Genders

Study Summary

The purpose of this study is to investigate whether there is a difference in endothelial function, heart rate variability and carotid intimal media thickness in patients with coronary artery disease who are receiving fish oil therapy.

One hundred patients with established coronary artery disease by coronary angiography will undergo randomization for enrollment in the study. Baseline evaluation will include assessment of brachial artery endothelial function, heart rate variability and carotid intimal media thickness. Evaluation of the endothelial function of the brachial artery will be elucidated by inflation of a blood pressure cuff around the arm for five minutes and measuring blood vessel dynamics after release of the cuff. Heart rate variability will be evaluated by 24 hour holter monitoring and analysis by standard protocol. Carotid intimal media thickness will be evaluated by ultrasound measurements guided by predetermined protocol. Patients will then be randomized to a highly purified fish oil, Omacor, 1 gram twice a day or placebo. Brachial artery ultrasound and holter monitoring will be repeated at 2 months. Carotid ultrasound will be repeated at the end of the study at 12 months.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Established coronary artery disease as determined by coronary angiography within thelast 5 years demonstrating at least 50% stenosis in one of the major coronary vessels

  2. Age >18 and <75.

Exclusion

Exclusion Criteria:

  1. Baseline fish oil intake ≥1g/day or fish intake >100g/day

  2. Need for urgent or emergent CABG

  3. Contraindication for plavix, aspirin or statin

  4. Gastrointestinal malabsorption syndrome

  5. Pregnancy

  6. Oral contraceptive use

  7. Ejection fraction <40%

  8. Underlying atrial or ventricular arrhythmia

  9. History of rheumatoid arthritis

Study Design

Total Participants: 71
Study Start date:
August 01, 2006
Estimated Completion Date:
December 31, 2008

Connect with a study center

  • OV-UCLA Medical Center

    Sylmar, California 91342
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.